BioSpace News Archive

While a handful of companies have dominated the COVID-19 vaccine market in the U.S. and Europe, a number of biotechs are continuing to develop vaccines to use as booster shots.

Ahead of a scheduled Advisory Committee meeting this week, the FDA released favorable remarks about the Pfizer-BioNTech and Moderna COVID-19 vaccines for children under the age of five.

ION582 is uniquely formulated using RNA technology to provide relief to patients with Angelman syndrome, a rare disorder for which limited treatment options are available.

Shares of CRISPR Therapeutics fell more than 11% on Monday as investors react negatively to the endorsement of a rival beta-thalassemia gene therapy developed by bluebird bio.

RELIEF THERAPEUTICS Holding SA reported that the parent company, NRx Pharmaceuticals, Inc., of its collaboration partner with respect to aviptadil, NeuroRx, Inc., has announced that the U.S. Food and Drug Administration has denied its most recent application seeking Breakthrough Therapy designation for aviptadil.

According to Transparency Market Research’s latest report on the global medical devices outsourcing market for the historical period 2017–2019 and forecast period 2021–2028, increase in geriatric population and rise in demand for upgrade of various medical devices are key factors projected to drive the global medical devices outsourcing market during the forecast period

According to Transparency Market Research’s latest report on the global fundus camera market for the historical period, 2017–2019, and forecast period, 2021–2028, increase in geriatric population across the globe and surge in incidence of retinal disorders are projected to drive the global fundus camera market during the forecast period

Augmented Reality-based Patient Positioning Systems Gaining Ground in Radiotherapy Applications in the U.S., States Fact.MR

Wilmington, Delaware, United States: According to Transparency Market Research’s latest report on the global regenerative medicine market for the historical period 2017–2018 and forecast period 2021–2028, increase in demand for customized regenerative medicine is projected to drive the global regenerative medicine market during the forecast period

The China Mixed Mode Chromatography Resin Market Is Regarded As The Fastest Growing In The Asia Pacific Region, With A Net Worth Of US$ 7.6 Million In 2022 And A Projected To Witness A CAGR Of 15% From 2022 To 2032.